Stocktoria
Silexion Therapeutics Corp SLXN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-17
Silexion Therapeutics Corp statistics & valuation
Market cap$2.9M
P / B1.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -165.1% | -577.0% | -97.2% |
| Return on equity | -457.6% | 414.1% | 33.0% |
| Current ratio | 2.41 | 0.64 | 2.27 |
Source: SEC EDGAR filings · CIK 0002022416 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.